Competing Interests Declaration The author(s) has no competing interests to declare that are relevant to the content of this manuscript
Although GLP-1 drugs are catching up to bariatric surgery in terms of their effectiveness in reducing obesity and related health conditions, they are expensive $900 to $1,350 per month and must be used indefinitely to maintain weight loss
Short-term: room temperature is fine, briefly Dry powder tolerates room temperature for days to weeks, such as during shipping
Most clinical trial data spans 1268 weeks, leaving questions about multi-year safety profiles unanswered
But step therapy can potentially harm a patient and make treatment longer and more expensive if an insurer first requires a treatment not recommended by the patients physician
This is a huge health crisis since obesity increases chances of diabetes, heart disease, cancer, and lots more